Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.
about
Mother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant?Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT.Women and Children First: The Impact of Sexually Transmitted Infections on Maternal and Child Health.Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.Temporal changes in the outcomes of HIV-exposed infants in Kinshasa, Democratic Republic of Congo during a period of rapidly evolving guidelines for care (2007-2013).Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical TrialHIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in UgandaA post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria.Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.Advances in therapy for the prevention of HIV transmission from mother to child.Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial.Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine.Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.The Voices That Influence HIV-Positive Mothers' Breastfeeding Practices in an Urban, Ghanaian Society.Breastfeeding and the 2015 South African guidelines for prevention of mother-to-child transmission of HIV.Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children.HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
P2860
Q27008774-BA65ACE0-9AC4-4F29-B156-FD415586280FQ33745946-EBE676B7-2EA0-4514-B673-E49FCD17DEC2Q35623620-DC7CE485-E4D9-4303-9461-4367FC6B6BEDQ35965344-C27F93E5-FB22-4EA8-91D0-45687D9CD21BQ36144271-C79E0685-6937-4244-B5C5-0BF8BB2FCC8CQ36306986-A96E048C-CD2B-4285-A491-FA3920DDFF0DQ37062207-FCAB80CC-9AEF-4341-A3BD-91F03BAF62FAQ37320315-AC0F38CA-2559-4935-8A32-6AC34BDF4936Q37410105-56C19C65-604E-4B53-974E-3BE5CFEFDAF5Q37543203-B1EF9D56-4E65-4A5C-8429-1695BA211310Q38853723-067F5157-B4CD-405A-9E7E-344ED4C4BAC2Q38874266-BEF02884-8884-4470-9190-E10B49F1AFB2Q38875150-BEB9FBF1-F153-4E8C-A271-1A16C6A6AF7DQ38913062-D336EDB6-D7B9-48CE-ACBA-83073E7E0F98Q39234019-1DFE8A89-DC98-42BF-9819-EE54A02C1023Q40238381-2AC0A60D-1114-480C-BAC3-5D4480A15385Q42010738-09AF6067-4D37-4B91-A3E1-DD35F456D81EQ42215713-BC9DB11C-6A27-4C79-8AC1-B5EA30EBC945Q47571136-417E12F4-AF51-4F5E-B8FD-2D7A2828F46AQ53800268-0064F3B5-C5AE-4547-A296-0CFBD78EB1F2Q55224546-AE856DBA-7E50-47BE-A4A9-B0107B08E0E5Q55256755-59965D67-ADB8-4891-93D0-ECA91B9837B9
P2860
Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Impact of antiretroviral drugs ...... stance and treatment outcomes.
@en
type
label
Impact of antiretroviral drugs ...... stance and treatment outcomes.
@en
prefLabel
Impact of antiretroviral drugs ...... stance and treatment outcomes.
@en
P2860
P50
P356
P1476
Impact of antiretroviral drugs ...... stance and treatment outcomes.
@en
P2093
Roger Paredes
P2860
P304
P356
10.1093/INFDIS/JIT110
P407
P478
207 Suppl 2
P577
2013-06-01T00:00:00Z